Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2

NCT02719756 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Hypoglycemic Episodes

Interventions

DRUG: Metformin
DRUG: Dapagliflozin
DRUG: Metformin up-titration

Sponsor

Research Clinical Centre of the Russian Railways, JSC